相关实验视频

Updated: Feb 24, 2026

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

单细胞转录学揭示了人类中脑类器官模型帕金森病的分子脆弱性

Jessica Jiaxin Xie^1,2, Matas Vitkauskas¹, Quyen Do¹

¹Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore 138672, Singapore.

|February 23, 2026

概括

人类中脑类器官 (hMLOs) 通过显示多巴胺神经元脆弱性来模拟帕金森病 (PD). 在hMLOs中PARK7基因淘汰重新总结了关键的PD病理,有助于机理学研究.

科学领域:

神经科学是一个神经科学.
发育生物学发展生物学
遗传学是一个遗传学.

背景情况:

人类中脑类器官 (hMLOs) 对于研究帕金森病 (PD) 病理学至关重要.
在hMLOs中了解PD中的细胞脆弱性需要详细的分子表征.

研究的目的:

在实验室内进行高达150天的hMLOs深入单细胞表征.
研究与PD相关的hMLOs中多巴胺产生神经元 (DaNs) 的分子格局和细胞脆弱性.
评估hMLOs在PD病理生理学建模中的实用性,包括PARK7基因的影响.

主要方法:

单细胞RNA测序hMLOs在体外长达150天.
多巴胺产生神经元 (DaN) 亚型的识别和表征.
在hMLOs中对PARK7的基因淘汰.
评估与PD相关的病理特征 (例如α-synuclein聚合,莱维体样包容,DaN退化).

主要成果:

hMLOs表现出类似于人类胎儿中脑的生理细胞类型和地形图案.
确定了四种不同的DaN亚型,其分子概况与PD中选择性DaN脆弱性有关.
在hMLOs中PARK7淘汰诱导了细胞类型特异性扰动和重复的关键PD病理,包括α-synuclein聚合和DaN退化.

结论:

该hMLO模型准确地反映了人类胎儿中脑发育和细胞组成.
已识别的DaN亚型及其转录组形状为PD相关的选择性脆弱性提供了洞察力.
hMLOs,特别是PARK7操纵的hMLOs,作为帕金森病机理学研究的宝贵平台.

关键词:

疾病疾病疾病细胞生物学的整合性方面分子神经科学分子神经科学文字转录学 (Transcriptomics) 是一个学科.

更多相关视频

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

Reliable Identification of Living Dopaminergic Neurons in Midbrain Cultures Using RNA Sequencing and TH-promoter-driven eGFP Expression

Reliable Identification of Living Dopaminergic Neurons in Midbrain Cultures Using RNA Sequencing and TH-promoter-driven eGFP Expression

Published on: February 10, 2017

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...